Ambulatory blood pressure monitoring (ABPM) can detect phenotypes associated with increased cardiovascular disease (CVD) risk. Diabetes is associated with increased CVD risk but few data are available documenting whether blood pressure (BP) phenotypes, detected by ABPM, differ between individuals with versus without diabetes. We conducted a cross-sectional analysis of 567 participants in the Jackson Heart Study, a population-based study of African Americans, taking antihypertensive medication to evaluate the association between diabetes and ABPM phenotypes. Two clinic BP measurements were taken at baseline following a standardized protocol. ABPM was performed for 24 h following the clinic visit. ABPM phenotypes included daytime, sustained, nocturnal and isolated nocturnal hypertension, a non-dipping BP pattern, and white coat, masked and masked isolated nocturnal hypertension. Diabetes was defined as fasting glucose ⩾ 126 mg dl − 1 , haemoglobin A1c ⩾ 6.5% (48 mmol mol
INTRODUCTION
Elevated blood pressure (BP) measured in the clinic setting is a well-established risk factor for cardiovascular disease (CVD) and end-stage renal disease among the general population as well as individuals with diabetes. [1] [2] [3] [4] Compared with measurements taken in the clinic setting, ambulatory blood pressure monitoring (ABPM) may provide a better estimate of an individual's average BP. 5, 6 In addition, a mismatch can exist between hypertension defined using clinic-measured BP and BP measured outside of the clinic setting. For example, some individuals with elevated clinic BP may have non-elevated BP when measured outside of the clinic setting by ABPM (that is, white coat hypertension). [5] [6] [7] [8] The opposite also occurs; some individuals with non-elevated clinic BP may have elevated BP when measured outside of the clinic setting (that is, masked hypertension). [5] [6] [7] [8] ABPM can also identify diurnal BP patterns, including BP that does not decline at night (that is, non-dipping BP) and elevated BP at night (that is, nocturnal hypertension). 5, 6 Several of these phenotypes, including elevated mean 24-h BP, elevated night-time BP and non-dipping BP pattern have been associated with increased CVD risk. 5, 9, 10 A recent study reported that individuals with versus without diabetes were more likely to have a higher daytime, and nighttime systolic BP (SBP) assessed by ABPM. 11 However, this study only included individuals with a clinical indication for ABPM, the results were not adjusted for potential confounders, it was conducted in a population of both treated and untreated individuals analysed together and it did not include African Americans. A high prevalence of abnormal BP phenotypes identified using ABPM among individuals with diabetes may indicate a role for ABPM to guide treatment of hypertension in this population. The objective of this study was to compare the prevalence of ABPM phenotypes among individuals with and without diabetes in a population-based cohort of AfricanAmerican adults taking antihypertensive medication. Phenotypes evaluated included out-of-office BP (daytime hypertension, sustained hypertension), diurnal BP patterns (nocturnal hypertension, isolated nocturnal hypertension, non-dipping pattern) and mismatches between clinic and out-of-clinic BP (white coat hypertension, masked hypertension and masked isolated nocturnal hypertension).
(Hinds, Madison and Rankin) that comprise the Jackson, Mississippi metropolitan area. Details of the design and conduct of the JHS have been published previously. 12, 13 The study enrolled 5301 African Americans between 2000 and 2004. Participants were invited to complete a 24-h ABPM session at baseline that 1146 volunteers completed. For the current analysis, we excluded participants with an incomplete ABPM reading (n = 100), missing clinic SBP (n = 5), missing diabetes status (n = 9) and missing (n = 58) or not taking antihypertensive medication (n = 407) for a final sample size of 567 participants. We restricted the analyses to participants taking antihypertensive medication as there were too few participants with diabetes not taking antihypertensive medication (n = 51) to perform analyses in this group. The protocol for the JHS was approved by the institutional review boards at the participating institutions, including Jackson State University, Tougaloo College and University of Mississippi Medical Center, and all participants provided written informed consent. The analyses of the data that we report were approved by the institutional review board at the University of Alabama at Birmingham.
Data collection
Data for the current analyses were collected by questionnaire, a clinic examination and ABPM. Data collected through the interviewadministered questionnaire included age, sex, education, marital status, current smoking, physical activity, history of stroke and myocardial infarction and self-reported use of antihypertensive medication. Using a modified Baecke questionnaire, duration, frequency and intensity of physical activity were reported in four domains (active living, work, home life and sports and exercise). 14, 15 Participants were considered to be taking antihypertensive medication if they self-reported use of medication to lower BP in the 2 weeks before their clinic visit. The names of all classes of antihypertensive medication being taken in the 2 weeks before the clinic visit were recorded at baseline during a pill bottle review. During the clinic examination, trained technicians measured height, weight and BP. Measured height and weight were used to calculate body mass index.
Participants were asked to fast overnight before their JHS examination. Venipuncture was done after participants were in a supine position for 20 min. Blood was collected within a designated 1-h time window following a standardized protocol. Total and high-density lipoprotein (HDL) cholesterol, serum glucose and haemoglobin A1c were measured from blood samples taken during the clinic examination. Total and HDL cholesterol were measured using a Roche COBAS Fara analyser ( b Analyses of white coat hypertension were restricted to participants with clinic hypertension. c Analyses of masked hypertension and masked isolated nocturnal hypertension were restricted to participants without clinic hypertension. sustained hypertension. Diurnal BP patterns included nocturnal hypertension, isolated nocturnal hypertension and a non-dipping BP pattern. Mismatches between clinical hypertension and out-of-clinic hypertension included white coat hypertension, masked hypertension and masked isolated nocturnal hypertension.
BP comparability study A Blood Pressure Comparability Study was conducted during the transition from the use of a Hawksley RZS to an Omron automatic oscillatory device (AOD; Omron Healthcare Inc, Lake Forest, IL, USA) in the second clinic visit. Two technicians took BP measurements simultaneously using a Y connector and double-headed stethoscope with the RZS and AOD devices. BP measurements obtained at baseline with the RZS were calibrated to measurements obtained with the AOD device using the following calibration equations to predict SBP and DBP:
This equation modelled the difference between the AOD and RZS as a function of RZS.
Statistical analysis
Characteristics were calculated for participants with and without diabetes, separately, and compared using t-tests and χ 2 tests as appropriate. The prevalence of clinic hypertension and BP phenotypes assessed by ABPM was calculated for participants with and without diabetes and were compared using χ 2 tests. Binomial regression models were used to calculate prevalence ratios (PRs) for each BP phenotype assessed by ABPM, comparing participants with versus without diabetes. Models with progressive adjustment were fitted. Model 1 adjusted for age and sex. Model 2 included additional adjustment for education, marital status, current smoking, physical activity and body mass index. Model 3 included all of the variables in model 2 plus history of stroke, history of myocardial infarction, total and HDL cholesterol and taking ⩾ 3 classes of antihypertensive medication. For the analysis of nocturnal hypertension, isolated nocturnal hypertension and non-dipping pattern, a fourth model (model 4) included adjustment for daytime SBP. In a sensitivity analysis, we defined masked hypertension as non-elevated clinic BP with elevated daytime BP and/or elevated night-time BP and we calculated PRs for masked hypertension associated with diabetes using this definition. We conducted an additional sensitivity analysis after calibrating the RZS BP measurements to the AOD as described above. All variables with missing data were imputed with 10 data sets using chained equations. 18 The percentage of data missing for each variable included in the analysis was 0.4% for education, 0.2% for marital status, 0.7% for current smoking, 8.8% for total cholesterol and 9.0% for HDL cholesterol. All analyses were conducted using STATA/IC 13 (Stata Corporation, College Station, TX, USA).
RESULTS
Of the 567 participants included in this analysis, the mean age was 62.3 years and 28.2% were male. Overall, 196 (34.6%) participants had diabetes. Body mass index was higher and HDL cholesterol was lower among participants with versus without diabetes ( Table 2) . Participants with diabetes were more likely than their counterparts without diabetes to be taking ⩾ 3 classes of antihypertensive medication (31.6% versus 17.8%). Mean 24-h, daytime and night-time SBP were higher and mean clinic DBP was lower among participants with diabetes compared with their counterparts without.
Elevated mean clinic and/or daytime BP The prevalence of clinic and sustained hypertension was similar among participants with diabetes compared with those without diabetes (Table 3) . Diabetes was associated with a higher prevalence of daytime hypertension. This association remained present after full multivariable adjustment.
Diurnal BP patterns
The prevalence of nocturnal hypertension and isolated nocturnal hypertension was higher among participants with diabetes compared with those without diabetes ( Table 4 ). The associations for nocturnal hypertension and isolated nocturnal hypertension remained statistically significant after age and sex adjustment and further adjustment for education, marital status, current smoking, physical activity, body mass index, history of stroke, history of myocardial infarction and total and HDL cholesterol. These associations were attenuated after adjustment for daytime SBP. The prevalence of non-dipping was not statistically significantly different between participants with diabetes and those without diabetes.
Mismatch between clinical hypertension and out-of-clinic hypertension status The prevalence of white coat hypertension was lower for participants with diabetes compared with those without diabetes (25.5% versus 35.5%, Table 5 ). In contrast, the prevalence of masked hypertension and masked isolated nocturnal hypertension was higher among participants with diabetes compared with those without diabetes. Diabetes was associated with a higher prevalence of masked hypertension and masked isolated nocturnal hypertension after multivariable adjustment. In a sensitivity analysis, diabetes was associated with an increased prevalence of masked hypertension when defined by nonelevated clinic BP with elevated daytime BP and/or elevated night-time BP (Supplementary Table 1) . Calibrated BP Diabetes was associated with masked hypertension and masked isolated nocturnal hypertension when BP measurements from the RZS were calibrated to the AOD (Supplementary Table 2) .
DISCUSSION
In the current study, the prevalence of daytime hypertension, masked hypertension and masked isolated nocturnal hypertension was higher among participants with diabetes compared with their counterparts without diabetes. In contrast, white coat hypertension, a phenotype that has not been consistently associated with increased CVD risk in most prior studies, was less prevalent among participants with diabetes. 19 Overall, these data suggest that ABPM may provide information on BP beyond that obtained from measurements taken in the clinic setting.
Previous analyses have reported differences in BP phenotypes assessed by ABPM among individuals with diabetes compared with their counterparts without diabetes, including those taking and not taking antihypertensive medication. 11, 20 Gorostidi et al. In addition, the prevalence of a non-dipping BP was more common among hypertensive individuals with diabetes (64.2%) compared with their counterparts without diabetes (51.6%). This study was restricted to a population with a clinical indication for ABPM, did not include African Americans and results were not presented after adjustment for potential confounders. In the current study, we found a similar prevalence of non-dipping pattern among participants with diabetes versus those without diabetes. The prevalence of non-dipping BP was high in both groups that is consistent with this pattern being more common among African Americans. 21 In IDACO, masked hypertension was more common in participants with diabetes versus those without diabetes (29.3% versus 18.8%), consistent with our findings. 20 However, these aforementioned studies did not include African Americans. African Americans are more likely than whites to have diabetes and many BP phenotypes assessed by ABPM, including masked hypertension, nocturnal hypertension and non-dipping BP. [22] [23] [24] The current study extends findings of prior studies to a large sample of African Americans with a high prevalence of diabetes.
Studies have shown that out-of-office BP have stronger associations with CVD outcomes when compared with clinic BP among individuals with diabetes. 25, 26 In a prospective study of 607 individuals with diabetes, a stronger association was present between mean asleep SBP with CVD events (hazard ratio: 1.71; 95% confidence interval (CI): 1.45-2.01 for each s.d. higher mean asleep SBP) compared with mean clinic SBP (hazard ratio: 1.44; 95% CI: 1.19-1.74 for each s.d. higher mean clinic SBP). 25 In a separate study of 565 individuals with diabetes, daytime and night-time SBP were associated with an increased risk of CVD events (hazard ratio: 1.45; 95% CI: 1.17-1.80 for 15 mm Hg higher daytime and hazard ratio: 1.37; 95% CI: 1.12-1.67 for each 17 mm Hg higher night-time SBP), whereas CVD risk was not increased at higher clinic SBP (hazard ratio: 1.16; 95% CI: 0.91-1.48, Table 1 for the definitions of nocturnal hypertension, isolated nocturnal hypertension and non-dipping pattern. Analyses of isolated nocturnal hypertension restricted to participants without elevated daytime hypertension. Model 1 is adjusted for age and sex. Model 2 is adjusted for variables in model 1 +education, marital status, current smoking, physical activity and body mass index. Model 3 is adjusted for variables in model 2+history of stroke, history of myocardial infarction, total and high-density lipoprotein (HDL) cholesterol and taking ⩾ 3 classes of antihypertensive medication. Model 4 is adjusted for variables in model 3+daytime systolic blood pressure.
for each 17 mm Hg higher clinic SBP). 26 Given the stronger association of BP assessed by ABPM versus clinic BP with CVD morbidity, further evaluating BP phenotypes assessed by ABPM in relation to CVD outcomes among individuals with diabetes may provide important information for guiding treatment this population.
Recent guidelines by the UK National Institute for Health and Clinical Excellence (NICE) and US Preventive Services Task Force (USPSTF) suggest that the diagnosis of clinic hypertension be confirmed using ABPM in efforts to avoid misdiagnosis and overtreatment. 27, 28 However, the NICE and USPSTF recommendations are focussed on diagnosing hypertension in untreated individuals and they did not mention recommendations for treated populations. The European Society of Hypertension (ESH) recommends the use of ABPM in individuals with diabetes for the identification of masked hypertension. 29 In a more recent position paper, the ESH highlighted the usefulness of ABPM in identifying non-dipping patterns and nocturnal hypertension in individuals with diabetes as these phenotypes are common in this population. 6 In the current study, the prevalence of masked and nocturnal hypertension was high, supporting the ESH recommendations for ABPM in individuals with diabetes.
The current study has several strengths, including the collection of ABPM and clinic BP following standardized protocols. Few population-based studies have conducted ABPM in African Americans and those that did had small sample sizes. [30] [31] [32] The current study included a large population- In conclusion, in the current population-based study of African Americans taking antihypertensive medication, daytime, masked and masked isolated nocturnal hypertension were more prevalent among participants with diabetes compared with those without diabetes. Nocturnal hypertension was more common among participants with diabetes but this association was no longer present after adjustment for daytime SBP. This study highlights the high prevalence of ABPM phenotypes among individuals with diabetes taking antihypertensive medication.
What is known about the topic?
• Elevated blood pressure is a known risk factor for cardiovascular disease.
• Compared with clinic blood pressure measurements, ambulatory blood pressure provides a better estimate of mean blood pressure.
• In a previous study, adults with diabetes versus those without diabetes were more likely to have higher daytime and night-time systolic blood pressure.
What this study adds?
• Among African Americans taking antihypertensive medication, there is a higher prevalence of daytime, masked, and masked isolated nocturnal hypertension in those with diabetes compared with those without diabetes.
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